Seven steps to successful internet interventions

Researchers from the University of Minnesota School of Public Health identified seven common themes for successful internet-based intervention programs in a study published in the Journal of Internet Medical Research.

Six study coordinators and five principal investigators at a large, U.S.-based land grant university were interviewed about the process of developing online interventions in the areas of alcohol policy, adolescent health, medication adherence and HIV  prevention in transgender persons and in men who have sex with men.

The study was conducted to provide practical advice to others who may be in the process of designing online health interventions from the perspective of researchers with experience in conducting these types of studies, said corresponding author Keith Horvath, PhD.

The researchers identified common factors: (1) hire a strong (or at least the right) research team, (2) take time to plan before beginning the design process, (3) recognize that vendors and researchers have differing values, objectives and language, (4) develop a detailed contract, (5) document all decisions and development activities, (6) use a content management system, and (7) allow extra time for testing and debugging your intervention.

"These defined values and objectives should prompt an open and explicit discussion about the scope of work, budget and other needs from the perspectives of each organization," the researchers wrote. "Because of the complexity of developing online interventions, researchers and practitioners should become familiar with the process and how it may differ from the development and implementation of in-person interventions or programs."

Read the full study.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.